iShares Biotechnology ETF Rating $212.50 -0.93 (-0.44%) Closing price 11/13/2026 04:00 PM EasternExtended Trading$211.25 -1.25 (-0.59%) As of 11/13/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOptions ChainOwnershipRatingsSEC FilingsShort Interest iShares Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.65Holdings in IBB have an aggregate rating of Moderate Buy based on 555 analyst ratings issued in the past year covering 25 companies (71.7% of the portfolio).IBB Aggregate Price Target$212.50High Prediction$212.50Average Prediction$212.50Low Prediction$212.50Holdings in IBB have an aggregate price target of $212.50 and a range of $212.50 to $212.50 covering 25 companies (71.7% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBB Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings8.90%GILDGilead Sciences$168.08+0.1%Moderate Buy$171.07 1.8%293.2825 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision8.36%AMGNAmgen$465.67-0.3%Hold$424.66 -8.8%333.9313 of 5 starsTrending NewsAnalyst Forecast7.84%VRTXVertex Pharmaceuticals$538.60-0.7%Moderate Buy$596.44 10.7%283.5233 of 5 stars6.41%MRNAModerna$223.37-3.4%Hold$113.75 -49.1%251.562 of 5 starsTrending NewsEarnings ReportAnalyst RevisionGap Down6.19%REGNRegeneron Pharmaceuticals$955.47+0.4%Moderate Buy$898.97 -5.9%313.7773 of 5 stars3.56%ARGXargenex$960.04-2.2%Moderate Buy$1,155.24 20.3%284.5226 of 5 starsAnalyst Forecast2.89%NTRANatera$319.09-1.2%Moderate Buy$394.31 23.6%233.3266 of 5 stars2.56%RVMDRevolution Medicines$172.29-2.3%Moderate Buy$262.75 52.5%243.4593 of 5 starsAnalyst ForecastInsider TradeAnalyst Revision2.52%BIIBBiogen$253.40+1.2%Moderate Buy$254.41 0.4%333.0628 of 5 starsPositive NewsAnalyst Upgrade2.36%ONCBeOne Medicines$416.54+0.1%Buy$440.57 5.8%183.6776 of 5 starsAnalyst ForecastInsider Trade2.22%ILMNIllumina$207.01-1.2%Hold$244.24 18.0%193.1236 of 5 starsTrending NewsInsider Trade2.05%GMABGenmab A/S$51.37-0.7%Buy$53.50 4.1%122.3412 of 5 starsAnalyst ForecastOptions VolumeAnalyst Revision1.70%INSMInsmed$121.16+2.6%Moderate Buy$196.52 62.2%263.4447 of 5 starsPositive News1.66%INCYIncyte$120.97-0.6%Hold$132.86 9.8%252.922 of 5 starsInsider Trade1.61%UTHRUnited Therapeutics$591.17-0.4%Moderate Buy$676.40 14.4%164.6502 of 5 starsInsider TradeAnalyst Revision1.44%ALNYAlnylam Pharmaceuticals$165.04+5.4%Moderate Buy$305.86 85.3%264.8412 of 5 starsGap Up1.41%ROIVRoivant Sciences$39.53-1.2%Moderate Buy$46.64 18.0%142.1294 of 5 starsTrending NewsAnalyst ForecastInsider Trade1.15%EXELExelixis$69.00-1.2%Hold$58.62 -15.1%182.3286 of 5 starsAnalyst Forecast1.14%NBIXNeurocrine Biosciences$167.40-1.2%Moderate Buy$202.59 21.0%244.9307 of 5 starsAnalyst Forecast1.10%CRLCharles River Laboratories International$338.27-0.7%Moderate Buy$311.67 -7.9%172.3942 of 5 starsAnalyst Forecast1.09%ASNDAscendis Pharma A/S$275.39+3.1%Moderate Buy$313.52 13.8%214.342 of 5 starsTrending NewsAnalyst Forecast1.01%MEDPMedpace$653.94-0.4%Hold$649.27 -0.7%132.7059 of 5 stars0.90%BBIOBridgeBio Pharma$78.30+0.2%Moderate Buy$104.42 33.4%223.7356 of 5 starsPositive NewsAnalyst Forecast0.80%HALOHalozyme Therapeutics$100.27-0.4%Hold$108.18 7.9%133.8347 of 5 starsAnalyst Downgrade0.78%TECHBio-Techne$72.80-0.1%Hold$68.92 -5.3%172.3628 of 5 starsPositive NewsEarnings Report This page (NASDAQ:IBB) was last updated on 11/15/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredSHOCKING! Prediction caught on cameraNewly released footage shows James Altucher pulling a document out of a briefcase on camera. It is a document ...Paradigm Press | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBB Stock Alerts